Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
Impact of bosentan on health-related quality of life and dyspnoea in idiopathic pulmonary fibrosis: the BUILD-1 trial
European Respiratory Journal , 09/03/09
Raghu G et al. – HRQL and dyspnoea changed minimally during the course of the study. Observations from exploratory analyses suggest benefits of bosentan on HRQL among patients who underwent SLB for diagnosis and merit further investigation.
Related Articles
Tumor necrosis factor inhibitors and lung disease: A paradox of efficacy and risk
Seminars in Arthritis and Rheumatism, 11/20/09
Relevance Score: 68%
Targeted Injury of Type II Alveolar Epithelial Cells Induces Pulmonary Fibrosis
American Journal of Respiratory and Critical Care Medicine, 10/28/09
Relevance Score: 68%
Evaluation of recently validated non- invasive formula using basic lung functions as new screening tool for pulmonary hypertension in idiopathic pulmonary fibrosis patients
Annals of Thoracic Medicine, 10/02/09
Relevance Score: 68%
The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis
Journal of Leukocyte Biology, 11/11/09
Relevance Score: 67%
Pulmonary nocardiosis in cystic fibrosis
Journal of Cystic Fibrosis, 10/07/09
Relevance Score: 67%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Chronic Obstructive Pulmonary Disease: Role of Bacteria and Updated Guide to Antibacterial Selection in the Older Patient
Drugs & Aging, 11/25/09
Effects of formoterol and salmeterol on cytokine release from monocyte-derived macrophages
European Respiratory Journal , 11/25/09
Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma
Journal of Allergy and Clinical Immunology, 11/25/09
Today in Cystic Fibrosis...keeping you current
Receive free subspecialty "5-minute updates" via email
Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis
European Respiratory Journal , 11/24/09
Continuous vs Thrice-Daily Ceftazidime for Elective Intravenous Antipseudomonal Therapy in Cystic Fibrosis
Infection, 09/22/09
Lung Transplantation in Patients with Cystic Fibrosis
Seminars in Respiratory and Critical Care Medicine, 09/17/09
Today in Restrictive Lung Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Incidence, Prevalence, and Clinical Course of Idiopathic Pulmonary Fibrosis: a Population-Based Study
Chest, 09/30/09
Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia
Respiratory Medicine, 10/06/09
Interstitial lung disease and sleep: What is known
Sleep Medicine, 09/23/09
Sponsor
Article Search
Sponsor


See Latest Articles


